Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
Open Access
- 22 December 2022
- journal article
- Published by Elsevier in AJPM Focus
- Vol. 2 (1) , 100060
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 25 references indexed in Scilit:
- Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control EvaluationClinical Infectious Diseases, 2017
- Measuring maternal Tdap and influenza vaccination rates: Comparison of two population-based methodsVaccine, 2017
- Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressantsBirth Defects Research Part A: Clinical and Molecular Teratology, 2016
- Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007–2013Vaccine, 2016
- Tetanus, Diphtheria, Pertussis Vaccination Coverage Before, During, and After Pregnancy — 16 States and New York City, 20112015
- First Pertussis Vaccine Dose and Prevention of Infant MortalityPediatrics, 2015
- Pertussis Epidemic — California, 20142014
- Vaccination with Tetanus, Diphtheria, and Acellular Pertussis Vaccine of Pregnant Women Enrolled in Medicaid — Michigan, 2011–20132014
- Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 20122013
- Trends in Pertussis Among Infants in the United States, 1980-1999JAMA, 2003